MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice

Journal of Clinical Investigation

Volumn 119, Issue 9, 2009, Pages 2772-2786

  Callis, Thomas E ^a   Pandya, Kumar ^b   Hee, Young Seok ^a   Tang, Ru Hang ^a,b   Tatsuguchi, Mariko ^a   Huang, Zhan Peng ^a   Chen, Jian Fu ^a   Deng, Zhongliang ^a,c   Gunn, Bronwyn ^a   Shumate, Janelle ^a   Willis, Monte S ^a,b   Selzman, Craig H ^a,b   Wang, Da Zhi ^a,d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 40; GAP JUNCTION PROTEIN; HORMONE BINDING PROTEIN; MICRORNA; MICRORNA 208A; MYOSIN HEAVY CHAIN; MYOSTATIN 2; THYROID HORMONE ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC CONDUCTIVITY; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GROWTH REGULATION; HEART ARRHYTHMIA; HEART CONDUCTION; HEART HYPERTROPHY; INTRON; MALE; MOLECULAR MECHANICS; MOUSE; MYH6 GENE; MYH7 GENE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CARDIAC MYOSINS; CARDIOMEGALY; DNA PRIMERS; GENE EXPRESSION; HEART; HEART CONDUCTION SYSTEM; INTRONS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICRORNAS; MOLECULAR SEQUENCE DATA; MYOSIN HEAVY CHAINS; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 70349202176     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI36154     Document Type: Article

References (83)

1. Filipowicz, W., Bhattacharyya, S.N., and Sonenberg, N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9:102-114.
2. Kiriakidou, M., et al. 2007. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell. 129:1141-1151. (Pubitemid 46891041)
3. Bagga, S., et al. 2005. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 122:553-563. (Pubitemid 41191154)
4. Humphreys, D.T., Westman, B.J., Martin, D.I., and Preiss, T. 2005. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc. Natl. Acad. Sci. U. S. A. 102:16961-16966. (Pubitemid 41692666)
5. Callis, T.E., Deng, Z., Chen, J.F., and Wang, D.Z. 2008. Muscling through the microRNA world. Exp. Biol. Med. (Maywood). 233:131-138.
6. Ambros, V. 2004. The functions of animal microRNAs. Nature. 431:350-355.
7. Kloosterman, W.P., and Plasterk, R.H. 2006. The diverse functions of microRNAs in animal development and disease. Dev. Cell. 11:441-450. (Pubitemid 44430905)
8. Callis, T.E., and Wang, D.Z. 2008. Taking microRNAs to heart. Trends Mol. Med. 14:254-260.
9. van Rooij, E., Liu, N., and Olson, E.N. 2008. MicroRNAs flex their muscles. Trends Genet. 24:159-166.
10. Chen, J.F., Callis, T.E., and Wang, D.Z. 2009. microRNAs and muscle disorders. J. Cell. Sci. 122:13-20.
11. Zhao, Y., Samal, E., and Srivastava, D. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 436:214-220. (Pubitemid 41021266)
12. Chen, J.F., et al. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38:228-233. (Pubitemid 43177239)
13. Zhao, Y., et al. 2007. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 129:303-317. (Pubitemid 46574975)
14. Chen, J.F., et al. 2008. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. U. S. A. 105:2111-2116.
15. Thum, T., et al. 2007. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation. 116:258-267. (Pubitemid 47196561)
16. van Rooij, E., et al. 2006. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. U. S. A. 103:18255-18260.
17. van Rooij, E., et al. 2007. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science. 316:575-579.
18. Lompre, A.M., Nadal-Ginard, B., and Mahdavi, V. 1984. Expression of the cardiac ventricular alphaand beta-myosin heavy chain genes is developmentally and hormonally regulated. J. Biol. Chem. 259:6437-6446. (Pubitemid 14108193)
19. Chien, K.R. 2000. Genomic circuits and the integrative biology of cardiac diseases. Nature. 407:227-232.
20. Frey, N., Katus, H.A., Olson, E.N., and Hill, J.A. 2004. Hypertrophy of the heart: a new therapeutic target? Circulation. 109:1580-1589. (Pubitemid 38451712)
21. Ventura, A., et al. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 132:875-886. (Pubitemid 351312807)
22. Gupta, M.P. 2007. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J. Mol. Cell. Cardiol. 43:388-403. (Pubitemid 47469981)
23. Passman, R.S., and Fishman, G.I. 1994. Regulated expression of foreign genes in vivo after germline transfer. J. Clin. Invest. 94:2421-2425.
24. Braunwald, E., and Bristow, M.R. 2000. Congestive heart failure: fifty years of progress. Circulation. 102:IV14-IV23.
25. Tatsuguchi, M., et al. 2007. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 42:1137-1141. (Pubitemid 46829201)
26. Cheng, Y., et al. 2007. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am. J. Pathol. 170:1831-1840. (Pubitemid 47339258)
27. Sayed, D., Hong, C., Chen, I.Y., Lypowy, J., and Abdellatif, M. 2007. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 100:416-424. (Pubitemid 46272414)
28. Krenz, M., et al. 2003. Analysis of myosin heavy chain functionality in the heart. J. Biol. Chem. 278:17466-17474. (Pubitemid 36799633)
29. Tardiff, J.C., et al. 2000. Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am. J. Physiol. Heart Circ. Physiol. 278:H412-H419.
30. Krenz, M., and Robbins, J. 2004. Impact of beta-myosin heavy chain expression on cardiac function during stress. J. Am. Coll. Cardiol. 44:2390-2397. (Pubitemid 39647615)
31. Pandya, K., Kim, H.S., and Smithies, O. 2006. Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo. Proc. Natl. Acad. Sci. U. S. A. 103:16864-16869. (Pubitemid 44737344)
32. Grimson, A., et al. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell. 27:91-105. (Pubitemid 46991392)
33. Lewis, B.P., Burge, C.B., and Bartel, D.P. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15-20.
34. Morkin, E. 1993. Regulation of myosin heavy chain genes in the heart. Circulation. 87:1451-1460. (Pubitemid 23133087)
35. Morkin, E. 2000. Control of cardiac myosin heavy chain gene expression. Microsc. Res. Tech. 50:522-531. (Pubitemid 30738002)
36. Lee, S.J. 2004. Regulation of muscle mass by myostatin. Annu Rev Cell Dev. Biol. 20:61-86.
37. Schuelke, M., et al. 2004. Myostatin mutation associated with gross muscle hypertrophy in a child. N. Engl. J. Med. 350:2682-2688. (Pubitemid 38788003)
38. Morissette, M.R., et al. 2006. Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circ. Res. 99:15-24.
39. Cook, S.A., Matsui, T., Li, L., and Rosenzweig, A. 2002. Transcriptional effects of chronic Akt activation in the heart. J. Biol. Chem. 277:22528-22533. (Pubitemid 34967227)
40. Shyu, K.G., Lu, M.J., Wang, B.W., Sun, H.Y., and Chang, H. 2006. Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. Eur. J. Clin. Invest. 36:713-719. (Pubitemid 44393930)
41. Shyu, K.G., Ko, W.H., Yang, W.S., Wang, B.W., and Kuan, P. 2005. Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes. Cardiovasc. Res. 68:405-414. (Pubitemid 41566560)
42. Ito, M., et al. 1999. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell. 3:361-370. (Pubitemid 29290676)
43. Wang, J.C., Walker, A., Blackwell, T.K., and Yamamoto, K.R. 2004. The Caenorhabditis elegans ortholog of TRAP240, CeTRAP240/let-19, selectively modulates gene expression and is essential for embryogenesis. J. Biol. Chem. 279:29270-29277. (Pubitemid 38915803)
44. Dupont, E., et al. 2001. Altered connexin expression in human congestive heart failure. J. Mol. Cell. Cardiol. 33:359-371. (Pubitemid 32537933)
45. Kaprielian, R.R., et al. 1998. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation. 97:651-660.
46. Kostin, S., et al. 2003. Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol. Cell. Biochem. 242:135-144. (Pubitemid 36240539)
47. Sepp, R., Severs, N.J., and Gourdie, R.G. 1996. Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy. Heart. 76:412-417. (Pubitemid 26390797)
48. Lo, C.W. 2000. Role of gap junctions in cardiac conduction and development: insights from the connexin knockout mice. Circ. Res. 87:346-348.
49. Simon, A.M., Goodenough, D.A., and Paul, D.L. 1998. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr. Biol. 8:295-298.
50. Guerrero, P.A., et al. 1997. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J. Clin. Invest. 99:1991-1998.
51. Gros, D.B., and Jongsma, H.J. 1996. Connexins in mammalian heart function. Bioessays. 18:719-730.
52. Ismat, F.A., et al. 2005. Homeobox protein Hop functions in the adult cardiac conduction system. Circ. Res. 96:898-903.
53. Takebayashi-Suzuki, K., Pauliks, L.B., Eltsefon, Y., and Mikawa, T. 2001. Purkinje fibers of the avian heart express a myogenic transcription factor program distinct from cardiac and skeletal muscle. Dev. Biol. 234:390-401. (Pubitemid 32552667)
54. Linhares, V.L., et al. 2004. Transcriptional regulation of the murine Connexin40 promoter by cardiac factors Nkx2-5, GATA4 and Tbx5. Cardiovasc. Res. 64:402-411.
55. Griffiths-Jones, S., Saini, H.K., van Dongen, S., and Enright, A.J. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36:D154-D158.
56. Weiss, A., and Leinwand, L.A. 1996. The mammalian myosin heavy chain gene family. Annu. Rev. Cell Dev. Biol. 12:417-439. (Pubitemid 26422720)
57. VanBuren, P., Harris, D.E., Alpert, N.R., and Warshaw, D.M. 1995. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ. Res. 77:439-444.
58. Patel, R., et al. 2001. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 104:317-324. (Pubitemid 32666954)
59. Abraham, W.T., et al. 2002. Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol. Med. 8:750-760.
60. Lowes, B.D., et al. 2002. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N. Engl. J. Med. 346:1357-1365.
61. Yasumura, Y., Takemura, K., Sakamoto, A., Kitakaze, M., and Miyatake, K. 2003. Changes in myocardial gene expression associated with beta-blocker therapy in patients with chronic heart failure. J. Card. Fail. 9:469-474. (Pubitemid 38055656)
62. Stansfield, W.E., et al. 2008. Proteasome inhibition promotes regression of left ventricular hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 294:H645-H650.
63. Ahmad, F., Seidman, J.G., and Seidman, C.E. 2005. The genetic basis for cardiac remodeling. Annu. Rev. Genomics Hum. Genet. 6:185-216.
64. Kuzman, J.A., Vogelsang, K.A., Thomas, T.A., and Gerdes, A.M. 2005. L-Thyroxine activates Akt signaling in the heart. J. Mol. Cell. Cardiol. 39:251-258. (Pubitemid 40995014)
65. Degens, H., et al. 2003. Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment. Am. J. Physiol. Heart Circ. Physiol. 284:H108-H115. (Pubitemid 36076276)
66. Chang, K.C., et al. 1997. Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts. J. Clin. Invest. 100:1742-1749.
67. Ching, G.W., et al. 1996. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart. 75:363-368.
68. Hornstein, E., and Shomron, N. 2006. Canalization of development by microRNAs. Nat. Genet. 38(Suppl.):S20-S24.
69. Flynt, A.S., Li, N., Thatcher, E.J., Solnica-Krezel, L., and Patton, J.G. 2007. Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat. Genet. 39:259-263. (Pubitemid 46184359)
70. Giraldez, A.J., et al. 2005. MicroRNAs regulate brain morphogenesis in zebrafish. Science. 308:833-838.
71. Boutz, P.L., Chawla, G., Stoilov, P., and Black, D.L. 2007. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev. 21:71-84. (Pubitemid 46089709)
72. Baek, D., et al. 2008. The impact of microRNAs on protein output. Nature. 455:64-71.
73. Selbach, M., et al. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature. 455:58-63.
74. Chen, F., et al. 2002. Hop is an unusual homeobox gene that modulates cardiac development. Cell. 110:713-723. (Pubitemid 35283961)
75. Shin, C.H., et al. 2002. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell. 110:725-735. (Pubitemid 35283962)
76. Kook, H., et al. 2003. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 112:863-871. (Pubitemid 38063744)
77. Olson, E.N. 2004. A decade of discoveries in cardiac biology. Nat. Med. 10:467-474.
78. Olson, E.N. 2006. Gene regulatory networks in the evolution and development of the heart. Science. 313:1922-1927. (Pubitemid 44497993)
79. Lewandoski, M., Meyers, E.N., and Martin, G.R. 1997. Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb. Symp. Quant. Biol. 62:159-168. (Pubitemid 28198533)
80. Mitchell, G.F., Jeron, A., and Koren, G. 1998. Measurement of heart rate and Q-T interval in the conscious mouse. Am. J. Physiol. 274:H747-H751. (Pubitemid 28158267)
81. Callis, T.E., Cao, D., and Wang, D.Z. 2005. Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes. Circ. Res. 97:992-1000. (Pubitemid 41668912)
82. Obernosterer, G., Martinez, J., and Alenius, M. 2007. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat. Protoc. 2:1508-1514. (Pubitemid 46952329)
83. Williams, H.M., and Ianuzzo, C.D. 1988. The effects of triiodothyronine on cultured neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. 20:689-699. (Pubitemid 18239705)